A mouse transgenic approach to induce β-catenin signaling in a temporally controlled manner

Transgenic Research

Volumn 20, Issue 4, 2011, Pages 827-840

  Mukherjee, Atish ^a   Soyal, Selma M ^a   Li, Jie ^a   Ying, Yan ^a   Szwarc, Maria M ^a   He, Bin ^a   Kommagani, Ramakrishna ^a   Hodgson, Myles C ^a   Hiremath, Minoti ^b   Cowin, Pamela ^c   Lydon, John P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

catenin; Induction deinduction; Mammary gland; TET ON; TETO N89 catenin; Transgenic mouse

Indexed keywords

BETA CATENIN; DOXYCYCLINE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL TRANSFORMATION; EPITHELIUM CELL; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MORPHOGENESIS; MOUSE; PATHOLOGY; PRENATAL DEVELOPMENT; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UDDER;

ANIMALS; BETA CATENIN; CELL TRANSFORMATION, NEOPLASTIC; DOXYCYCLINE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, TRANSGENIC; MORPHOGENESIS; SIGNAL TRANSDUCTION;

MURINAE; MUS MUSCULUS;

EID: 79960449155     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-010-9466-6     Document Type: Article

References (51)

1. Aberle H, Bauer A, Stappert J et al (1997) Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797-3804.
2. Behrens J, von Kries JP, Kuhl M et al (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382: 638-642.
3. Behrens J, Jerchow BA, Wurtele M et al (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280: 596-599.
4. Bernstein L, Ross RK (1993) Endogenous hormones and breast cancer risk. Epidemiol Rev 15: 48-65.
5. Bierie B, Nozawa M, Renou JP et al (2003) Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation. Oncogene 22: 3875-3887.
6. Blakely CM, Sintasath L, D'Cruz CM et al (2005) Developmental stage determines the effects of MYC in the mammary epithelium. Development 132: 1147-1160.
7. Cadigan KM, Nusse R (1997) Wnt signaling: a common theme in animal development. Genes Dev 11: 3286-3305.
8. Chang H, Guillou F, Taketo MM et al (2009) Overactive beta-catenin signaling causes testicular sertoli cell tumor development in the mouse. Biol Reprod 81: 842-849.
9. D'Cruz CM, Gunther EJ, Boxer RB et al (2001) c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med 7: 235-239.
10. Fernandez-Valdivia R, Mukherjee A, Creighton CJ et al (2008) Transcriptional Response of the Murine Mammary Gland to Acute Progesterone Exposure. Endocrinology 149: 6236-6250.
11. Fernandez-Valdivia R, Mukherjee A, Ying Y et al (2009) The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse. Dev Biol 328: 127-139.
12. Fodde R, Brabletz T (2007) Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19: 150-158.
13. Gounari F, Signoretti S, Bronson R et al (2002) Stabilization of beta-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia. Oncogene 21: 4099-4107.
14. Grigoryan T, Wend P, Klaus A et al (2008) Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev 22: 2308-2341.
15. Gumbiner BM (1995) Signal transduction of beta-catenin. Curr Opin Cell Biol 7: 634-640.
16. Gunther EJ, Belka GK, Wertheim GB et al (2002) A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. Faseb J 16: 283-292.
17. Guo Z, Dose M, Kovalovsky D et al (2007) Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation. Blood 109: 5463-5472.
18. Harada N, Tamai Y, Ishikawa T et al (1999) Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 18: 5931-5942.
19. Hatsell S, Rowlands T, Hiremath M et al (2003) Beta-catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia 8: 145-158.
20. He TC, Sparks AB, Rago C et al (1998) Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
21. Hiremath M, Lydon JP, Cowin P (2007) The pattern of beta-catenin responsiveness within the mammary gland is regulated by progesterone receptor. Development 134: 3703-3712.
22. Imbert A, Eelkema R, Jordan S et al (2001) Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol 153: 555-568.
23. Jeong JW, Lee HS, Franco HL et al (2009) Beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus. Oncogene 28: 31-40.
24. Kaplan E, Meier P (1958) Non-parametric estimation for incomplete observation. J Am Stat Assoc 53: 457-471.
25. Leder A, Pattengale PK, Kuo A et al (1986) Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45: 485-495.
26. Lewandoski M (2001) Conditional control of gene expression in the mouse. Nat Rev Genet 2: 743-755.
27. Liu C, Li Y, Semenov M et al (2002) Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108: 837-847.
28. Lydon JP, Ge G, Kittrell FS et al (1999) Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res 59: 4276-4284.
29. MacMahon B, Cole P, Lin TM et al (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43: 209-221.
30. Marchant J (1955) Influence of pregnancy and lactation on the incidence of mammary carcinoma induced with methylcholanthrene in female mice of the "IF" strain. J Pathol Bacteriol 70: 415-418.
31. Medina D, Smith GH (1999) Chemical carcinogen-induced tumorigenesis in parous, involuted mouse mammary glands. J Natl Cancer Inst 91: 967-969.
32. Miyoshi K, Hennighausen L (2003) Beta-catenin: a transforming actor on many stages. Breast Cancer Res 5: 63-68.
33. Mukherjee A, Soyal SM, Fernandez-Valdivia R et al (2007) Targeting reverse tetracycline-dependent transactivator to murine mammary epithelial cells that express the progesterone receptor. Genesis 45: 639-646.
34. Mukherjee A, Soyal SM, Li J et al (2010) Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. FASEBJ 24: 4408-4419.
35. Munemitsu S, Albert I, Souza B et al (1995) Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci U S A 92: 3046-3050.
36. Munemitsu S, Albert I, Rubinfeld B et al (1996) Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein. Mol Cell Biol 16: 4088-4094.
37. Peto R, Peto J (1972) Asymptotically efficient rank invariant test procedures. J R Stat Soc A 135: 185-207.
38. Peto R, Pike MC, Day NE et al (1980) Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. IARC Monogr Eval Carcinog Risk Chem Hum Suppl 2: 311-426.
39. Polakis P (1999) The oncogenic activation of beta-catenin. Curr Opin Genet Dev 9: 15-21.
40. Reynolds SD, Zemke AC, Giangreco A et al (2008) Conditional stabilization of beta-catenin expands the pool of lung stem cells. Stem Cells 26: 1337-1346.
41. Russo J, Tay LK, Russo IH (1982) Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 2: 5-73.
42. Sawyers CL (2009) Shifting paradigms: the seeds of oncogene addiction. Nat Med 15: 1158-1161.
43. Shimizu H, Julius MA, Giarre M et al (1997) Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ 8: 1349-1358.
44. Shtutman M, Zhurinsky J, Simcha I et al (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 96: 5522-5527.
45. Teissedre B, Pinderhughes A, Incassati A et al (2009) MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors. PLoS One 4: e4537.
46. Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426.
47. Teuliere J, Faraldo MM, Deugnier MA et al (2005) Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development 132: 267-277.
48. Wang TC, Cardiff RD, Zukerberg L et al (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669-671.
49. Wang Y, Krivtsov AV, Sinha AU et al (2010) The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 327: 1650-1653.
50. Yost C, Torres M, Miller JR et al (1996) The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev 10: 1443-1454.
51. Zechner D, Fujita Y, Hulsken J et al (2003) Beta-catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system. Dev Biol 258: 406-418.